Challenge studies in chickens to evaluate the efficacy of commercial Newcastle disease vaccines against the strains of Newcastle disease virus prevalent in South Africa since 2002

Show simple item record

dc.contributor.advisor Bisschop, Shahn P.R. en
dc.contributor.advisor Duncan, Neil M. en
dc.contributor.postgraduate Bwala, Dauda Garba
dc.date.accessioned 2013-09-06T13:50:57Z
dc.date.available 2010-03-12 en
dc.date.available 2013-09-06T13:50:57Z
dc.date.created 2009-11-27 en
dc.date.issued 2010-03-12 en
dc.date.submitted 2010-02-26 en
dc.description Dissertation (MSc (Veterinary Science))--University of Pretoria, 2009. en
dc.description.abstract Since 2002, the South African poultry industry has experienced outbreaks of Newcastle disease (ND) caused by a newly introduced virus (NDV) strain belonging to lineage 5d/VIId (“goose paramyxovirus” - GPMV). Control of the disease has proved difficult with commercially available vaccines appearing ineffective. In the first of two studies, broilers chicks were vaccinated with VG-GA vaccine (lineage II), then challenged with both GPMV and a “classic” challenge virus (RCV) of lineage 3d/VIII to compare the efficacy of the vaccine against both strains. In the second study, commercial and SPF hens in lay were vaccinated with La Sota vaccine and challenged with GPMV isolate, and immunohistochemistry staining used to determine the distribution pattern of viral antigen in the oviduct of the hens. The second study also compared the efficacy of cloacal and ocular routes of vaccination. The first study did not detect any statistically significant difference in protection offered by the vaccine against the GPMV strain in comparison to the RCV strain. The protection offered by the vaccine against challenge with both viruses was found to be dosedependant with 106.0 EID50 producing a 100% protection and 94.44% and 13.89% for 104.5 EID50 and 103.0 EID50 vaccination doses respectively. Protected birds did not manifest clinical signs, but still had macropathological lesions in some organs at necropsy. The computed protective doses (PD50 and PD90) for the VG-GA vaccine were 103.51 and 104.38 for GPMV and 103.79 and 104.43 for RCV. Results from the second study showed no clear difference in the protection of the oviduct from challenge with GPMV by either the cloacal and ocular routes of vaccination. Vaccinated birds were fully protected (100%) against challenge by La Sota vaccine, but not against infection and replication of the virus, as birds showed varying degrees of macropathology with numerous stained viral antigens in the oviducts demonstrated by immunohistochemistry. The susceptibility and colonisation of the oviduct of laying hens by both the lentogenic La Sota and the virulent NDV isolates was confirmed, with the uterus being more susceptible than magnum and isthmus. Necrosis and apoptosis of cells of the oviduct were not detected but cellular infiltration, gland dilatation and interstitial oedema were observed. en
dc.description.availability unrestricted en
dc.description.department Production Animal Studies en
dc.identifier.citation Bwala, DG 2009, Challenge studies in chickens to evaluate the efficacy of commercial Newcastle disease vaccines against the strains of Newcastle disease virus prevalent in South Africa since 2002, MSc (Veterinary Science) dissertation, University of Pretoria, Pretoria, viewed yymmdd < http://hdl.handle.net/2263/22859 > en
dc.identifier.other E10/28/gm en
dc.identifier.upetdurl http://upetd.up.ac.za/thesis/available/etd-02262010-123322/ en
dc.identifier.uri http://hdl.handle.net/2263/22859
dc.language.iso en
dc.publisher University of Pretoria en_ZA
dc.rights © 2009, University of Pretoria. All rights reserved. The copyright in this work vests in the University of Pretoria. No part of this work may be reproduced or transmitted in any form or by any means, without the prior written permission of the University of Pretoria. en
dc.subject Newcastle disease virus (NDV) en
dc.subject Chickens en
dc.subject South Africa (SA) en
dc.subject UCTD en_US
dc.title Challenge studies in chickens to evaluate the efficacy of commercial Newcastle disease vaccines against the strains of Newcastle disease virus prevalent in South Africa since 2002 en
dc.type Dissertation en


Files in this item

This item appears in the following Collection(s)

Show simple item record